Substance Abuse and Mental Health Services Administration February 2024 – Federal Register Recent Federal Regulation Documents

Notice of Meeting for the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC)
Document Number: 2024-03165
Type: Notice
Date: 2024-02-15
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Secretary of Health and Human Services announces a meeting of the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC). The meeting will provide information on federal efforts related to serious mental illness (SMI) and serious emotional disturbance (SED); the Olmstead Decision: 25 Years of History in the Making; SMI Advisor: A Modern Approach to Technical Assistance that Makes an Impact; and Report Outs from Focus Area 1Data and Evaluation; Focus Area 2 Access and Engagement; Focus Area 3Treatment and Recovery; Focus Area 4Criminal Justice and Focus Area 5Finance.
Notice of Meeting
Document Number: 2024-02640
Type: Notice
Date: 2024-02-09
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Meeting of the Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention National Advisory Council
Document Number: 2024-02063
Type: Notice
Date: 2024-02-02
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Notice is hereby given for the meeting on February 27, 2024, of the Center for Substance Abuse Prevention National Advisory Council (CSAP NAC). The meeting is open to the public and can also be accessed virtually. Agenda with call-in information will be posted on the SAMHSA website prior to the meeting at: https://www.samhsa.gov/about-us/ advisory-councils/meetings . The meeting will include, but not be limited to, remarks from the Assistant Secretary for Mental Health and Substance Use; approval of the meeting minutes of August 29, 2023; overview of CSAP strategic planning activities; presentations on substance use prevention priorities; Council discussion and public comments.
Meeting of the Substance Abuse and Mental Health Services Administration National Advisory Council
Document Number: 2024-02074
Type: Notice
Date: 2024-02-02
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Notice is hereby given for the meeting on February 29, 2024, of the Substance Abuse and Mental Health Services Administration National Advisory Council (SAMHSA NAC). The meeting is open to the public and can also be accessed virtually. Agenda with call-in information will be posted on the SAMHSA website prior to the meeting at: https://www.samhsa.gov/about-us/advisory-councils/meetings. The meeting will include, but not be limited to, remarks from the Assistant Secretary for Mental Health and Substance Use; consideration and approval of the meeting minutes of August 31, 2023; a recap of the JNAC of February 28, 2024, and Lessons Learned; a presentation and discussion on the following topics: Recovery Oriented Systems of Care (ROSC); the Release of the National Strategy for Suicide Prevention (NSSP) and how 988 fits into it; Homelessness; and general Council discussion and Public Comments.
Joint Meeting of the National Advisory Councils
Document Number: 2024-02073
Type: Notice
Date: 2024-02-02
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies
Document Number: 2024-01981
Type: Notice
Date: 2024-02-01
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies Federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITFs) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine or Oral Fluid (Mandatory Guidelines).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.